101 related articles for article (PubMed ID: 3900456)
1. [Clinical evaluation of the TMS-19-Q.GC tablet on superficial suppurative disease. A comparative double blind study with midecamycin].
Watanabe S; Kukita A; Miura Y; Tsukinaga I; Tagami H; Tanita Y; Nonami E; Shishiba T; Fujita K; Shigeno Y
Jpn J Antibiot; 1985 May; 38(5):1331-54. PubMed ID: 3900456
[TBL] [Abstract][Full Text] [Related]
2. [Clinical evaluation of the TMS-19-Q.GC tablet in odontogenic infections. A comparative double-blind study with josamycin].
Sasaki J; Yamada Y; Morihana K; Kaneko A; Takai H; Ohmura H; Abe H; Ikeshima K; Sesimo Y; Mishina M
Jpn J Antibiot; 1985 May; 38(5):1389-419. PubMed ID: 3900458
[TBL] [Abstract][Full Text] [Related]
3. [Clinical evaluation of the TMS-19-Q.GC tablet in acute tonsillitis. A comparative double blind study with josamycin].
Baba S; Kinoshita H; Mori Y; Sanbe B; Ueda R; Kawamura S; Sugita R; Fujimaki Y; Nomura Y; Kawabata I
Jpn J Antibiot; 1985 May; 38(5):1368-88. PubMed ID: 3900457
[TBL] [Abstract][Full Text] [Related]
4. [Comparative clinical study of roxithromycin and josamycin for suppurative skin and soft tissue infections by a double-blind method].
Nohara N; Akagi O; Kanzaki H; Kanamoto A; Ohara A; Ohkawara A; Fukaya T; Kobayashi H; Yasuda H; Tagami H
Kansenshogaku Zasshi; 1989 Mar; 63(3):203-27. PubMed ID: 2504834
[TBL] [Abstract][Full Text] [Related]
5. [Clinical and bacteriological evaluation of TMS-19-Q in superficial suppurative skin and soft tissue infection].
Watanabe S; Takizawa K; Shimada S; Yamada K; Nakagawa H; Kukita A; Miura Y; Tsukinaga I; Tagami H; Tanita Y
Jpn J Antibiot; 1985 Mar; 38(3):575-94. PubMed ID: 3897600
[TBL] [Abstract][Full Text] [Related]
6. [Clinical evaluation of TMS-19-Q, a new macrolide antibiotic, in otorhinolaryngological infections].
Baba S; Wada K; Hatano T; Murai K; Kinoshita H; Kawamura S; Sugita R; Fujimaki Y; Sanbe B; Ueda R
Jpn J Antibiot; 1985 Mar; 38(3):595-614. PubMed ID: 3897601
[TBL] [Abstract][Full Text] [Related]
7. [Clinical studies of rokitamycin dry syrup on skin and soft tissue infections in the pediatric fields].
Motohiro T; Aramaki M; Oda K; Kawakami A; Tanaka K; Koga T; Fujimoto T; Sakata Y; Nishiyama T; Yamashita F
Jpn J Antibiot; 1988 Oct; 41(10):1503-16. PubMed ID: 3204657
[TBL] [Abstract][Full Text] [Related]
8. [Clinical studies on TMS-19-Q.O tablets, the preparation of a new macrolide antibiotic, in the field of oral surgery].
Sasaki J; Yamada Y; Takai H; Ohmura H; Abe H; Shiki K; Narita Y; Michi K; Ohno K; Kawanishi I
Jpn J Antibiot; 1985 Mar; 38(3):615-33. PubMed ID: 3897602
[TBL] [Abstract][Full Text] [Related]
9. [Comparative study of TMS-19-Q and midecamycin for respiratory tract infection by double-blind method].
Kobayashi H; Nihei T; Takeda H; Kohno K; Saito A; Tomizawa M; Nakayama I; Hiraga Y; Kikuchi K; Yamamoto A
Kansenshogaku Zasshi; 1985 Feb; 59(2):201-26. PubMed ID: 3925037
[No Abstract] [Full Text] [Related]
10. [Clinical studies on TMS-19-Q.O tablet in respiratory tract infection].
Hara K; Izumikawa K; Suzuyama Y; Shigeno Y; Komori M; Tomita H; Sai M; Ikebe A; Iwasaki H; Saito A
Jpn J Antibiot; 1985 Mar; 38(3):553-74. PubMed ID: 3897599
[TBL] [Abstract][Full Text] [Related]
11. [Bacteriological, pharmacokinetic and clinical studies on a rokitamycin dry syrup in the pediatric field].
Toyonaga Y; Sugita M; Joh K; Takahashi T; Watanabe Y; Hori M
Jpn J Antibiot; 1988 Jun; 41(6):720-38. PubMed ID: 3265445
[TBL] [Abstract][Full Text] [Related]
12. [Clinical evaluation of lenampicillin in the treatment of superficial suppurative skin and soft tissue infection. A double-blind study comparing amoxicillin].
Fujita K; Takahashi H; Mizoguchi A; Takeshima M; Sasaki J; Nonami E; Harada S; Sato K; Hyang YS; Horie N
Jpn J Antibiot; 1985 Jul; 38(7):1794-818. PubMed ID: 3906167
[TBL] [Abstract][Full Text] [Related]
13. [Effect of metabolites on the human plasma concentration as total activity after oral administration of rokitamycin. Comparison of three different bioassay methods].
Morishita M; Sakai A; Endo S; Suzuki T
Jpn J Antibiot; 1987 Mar; 40(3):553-60. PubMed ID: 3302343
[TBL] [Abstract][Full Text] [Related]
14. [Bacteriological, pharmacokinetic and clinical studies of a rokitamycin syrup in pediatrics].
Sato H; Narita A; Matsumoto K; Nakazawa S; Suzuki H; Nakanishi Y; Nakazawa S; Chikaoka H; Koido R; Kamigaki M
Jpn J Antibiot; 1988 Jun; 41(6):696-711. PubMed ID: 3221434
[TBL] [Abstract][Full Text] [Related]
15. [Clinical application of rokitamycin in pediatrics].
Yanagawa Y; Fujita M; Hayakawa H
Jpn J Antibiot; 1988 Jul; 41(7):871-4. PubMed ID: 3172460
[TBL] [Abstract][Full Text] [Related]
16. [Studies of isolated organisms from otorhinolaryngological infections and their susceptibilities to macrolide antibiotics].
Baba S; Kinoshita H; Mori Y; Suzuki K; Shimada J; Kawamura S; Sugita R; Fujimaki Y; Sanbe B; Ogura S
Jpn J Antibiot; 1985 May; 38(5):1355-67. PubMed ID: 3930804
[TBL] [Abstract][Full Text] [Related]
17. [Clinical studies on 9, 3"-diacetylmidecamycin in respiratory tract infections in the field of pediatrics (author's transl)].
Iwai N; Sasaki A; Taneda Y; Mizoguchi F; Nakamura H
Jpn J Antibiot; 1982 Mar; 35(3):739-53. PubMed ID: 6285015
[TBL] [Abstract][Full Text] [Related]
18. [Clinical study on 9,3"-diacetylmidecamycin in the field of pediatrics (author's transl)].
Minamitani M; Hachimori K; Suzuki M
Jpn J Antibiot; 1982 Apr; 35(4):909-18. PubMed ID: 6980295
[TBL] [Abstract][Full Text] [Related]
19. [Clinical results of a rokitamycin dry syrup in pediatric infections].
Kawauchi K; Sato Y; Kimura S; Yonesaka S; Yokoyama M; Onishi A; Asuka T; Okamoto T; Takebe Y; Tsushima T
Jpn J Antibiot; 1988 Jun; 41(6):673-85. PubMed ID: 3221432
[TBL] [Abstract][Full Text] [Related]
20. Roxithromycin in skin and soft tissue infections.
Agache P; Amblard P; Moulin G; Barrière H; Texier L; Beylot C; Bergoend H
J Antimicrob Chemother; 1987 Nov; 20 Suppl B():153-6. PubMed ID: 3323167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
